Patent · US Active

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders

US7834060B2 · kind B2 · utility

2Cited by

9References

35Claims

0Family size

Assignee

GALDERMA RESEARCH & DEVELOPMENT · FR

Inventors

Michael Graeber · Berlin, DE
Janusz Czernielewski · Montargis, FR

Key dates

Filing date	May 7, 2009
Grant date	Nov 16, 2010
Priority date	—
Expiry date	Jul 11, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.